NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Autocrine Epo signaling inhibits hypoxia-induced apoptosis in cancer cells



December 23rd, 2004

According to a study from the United States, "Disordered perfusion and the resulting hypoxia are important features conferring tumor heterogeneity, which may contribute to relapse.

"Hypoxic tumor cells have been associated with resistance both to radiation and to cytotoxic drugs. Hypoxia may also serve as a selection pressure in tumors by promoting apoptosis of some cells and expanding variants with decreased apoptotic potential, and thus play a role in the development of a more aggressive phenotype," wrote G. Acs and colleagues, University of Pennsylvania.

"Erythropoietin (Epo), induced by hypoxia, controls erythropoiesis and plays a role in...


Source: Women's Health Weekly (2004-12-23)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login